Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 1998-04-01 (28 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VITRY-LE-FRANCOIS (51300), Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SNC PHARMACIE WILL : revenue, balance sheet and financial ratios
SNC PHARMACIE WILL is a French company
founded 28 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VITRY-LE-FRANCOIS (51300),
this company of category PME
shows in 2021 a net income positive of 19 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SNC PHARMACIE WILL (SIREN 418637872)
Indicator
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
19 065 €
32 775 €
45 778 €
50 108 €
56 316 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2021, SNC PHARMACIE WILL generates positive net income of 19 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2021: 56 k€ -> 19 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
19 065 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
13.488%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
78.112%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
Debt ratio
67.667
46.222
30.633
22.719
13.488
Financial autonomy
54.103
61.957
68.351
73.336
78.112
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
13.492021
2019
2020
2021
Q1: 29.03
Med: 85.54
Q3: 208.44
Excellent
In 2021, the debt ratio of SNC PHARMACIE WILL (13.49) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
78.11%2021
2019
2020
2021
Q1: 25.88%
Med: 44.4%
Q3: 64.18%
Excellent
In 2021, the financial autonomy of SNC PHARMACIE WILL (78.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 204.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
204.303
Liquidity indicators evolution SNC PHARMACIE WILL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
Liquidity ratio
258.687
242.064
220.151
235.552
204.303
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
204.32021
2019
2020
2021
Q1: 139.19
Med: 190.69
Q3: 259.61
Good-14 pts over 3 years
In 2021, the liquidity ratio of SNC PHARMACIE WILL (204.30) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SNC PHARMACIE WILL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of SNC PHARMACIE WILL is estimated at
218 683 €
(range 140 614€ - 337 797€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
140k€218k€337k€
218 683 €Range: 140 614€ - 337 797€
NAF 5 année 2021
Valuation method used
Net Income Multiple
19 065 €
×
11.5x
=218 683 €
Range: 140 615€ - 337 797€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SNC PHARMACIE WILL with other companies in the same sector:
Frequently asked questions about SNC PHARMACIE WILL
What is the revenue of SNC PHARMACIE WILL ?
The revenue of SNC PHARMACIE WILL is not publicly disclosed (confidential accounts filed with INPI).
Is SNC PHARMACIE WILL profitable?
Yes, SNC PHARMACIE WILL generated a net profit of 19 k€ in 2021.
Where is the headquarters of SNC PHARMACIE WILL ?
The headquarters of SNC PHARMACIE WILL is located in VITRY-LE-FRANCOIS (51300), in the department Marne.
Where to find the tax return of SNC PHARMACIE WILL ?
The tax return of SNC PHARMACIE WILL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SNC PHARMACIE WILL operate?
SNC PHARMACIE WILL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart